anmelden
SPI
18.575,43
PKT
+0,89
PKT
±0,00
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.22 | Holcim Overweight | Barclays Capital | |
| 18.01.22 | Givaudan Neutral | UBS AG | |
| 18.01.22 | Clariant Neutral | UBS AG | |
| 18.01.22 | Holcim Hold | Jefferies & Company Inc. | |
| 18.01.22 | ams-OSRAM Underweight | Barclays Capital | |
| 18.01.22 | Nestlé Buy | UBS AG | |
| 18.01.22 | UBS Overweight | Barclays Capital | |
| 18.01.22 | Richemont Overweight | Morgan Stanley | |
| 18.01.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.01.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.01.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.01.22 | Nestlé Overweight | Barclays Capital | |
| 17.01.22 | Holcim Overweight | Morgan Stanley | |
| 17.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 17.01.22 | Roche Buy | Deutsche Bank AG | |
| 17.01.22 | Clariant Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | Zurich Insurance Buy | HSBC | |
| 14.01.22 | Nestlé Overweight | Barclays Capital | |
| 14.01.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 14.01.22 | Novartis Equal-weight | Morgan Stanley | |
| 13.01.22 | ams-OSRAM Neutral | Credit Suisse Group | |
| 13.01.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 13.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.01.22 | DocMorris Add | Baader Bank | |
| 12.01.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.01.22 | Holcim Buy | UBS AG | |
| 11.01.22 | UBS Sector Perform | RBC Capital Markets | |
| 11.01.22 | Richemont Overweight | Barclays Capital | |
| 11.01.22 | Roche Buy | Deutsche Bank AG | |
| 11.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.01.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.01.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 11.01.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 10.01.22 | Richemont Outperform | RBC Capital Markets | |
| 10.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.01.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 07.01.22 | UBS Neutral | UBS AG | |
| 07.01.22 | Novartis Neutral | UBS AG |